Only PPP1R3C mRNA expression was consistent to the RNA-sequence data, showing significantly increase in NAFLD rats compared to Normal rats, while markedly decrease upon LGZG intervention (Fig. 2f). This evidence concerns the gene PPP1R3C and metabolic dysfunction-associated steatotic liver disease.